J&J Woes, Pharma Switch Outlook Lead "The Tan Sheet" 2010 Topics

Quality control problems for Johnson & Johnson's McNeil Consumer Healthcare business and the regulatory and congressional scrutiny that followed dominated the attention of drug and dietary supplement industry stakeholders in 2010.

More from Archive

More from HBW Insight